Drug Chatter -- Tracking biopharma stock chatter

Profile for TRACON Pharmaceuticals, Inc. (TCON)

« Back to company index

TCON Chatter Timeline

Stock Ticker for TCON

Most Active Tweeters for TCON

UserTweets
@SolarMelt 2
@WeekHerald 2
@TheMarketsDaily 2
@dispatchtribune 1
@Stock_News_Now 1

Recent Tweets for TCON

SolarMelt @SolarMelt
$TCON Quick Update Mid18 - P1/2 Dose Dose Escalation Data - TRC253 (Prostate Cancer) 2H18 - P3 IA - TRC105 (Angios… https://t.co/0iuiNLIMei
May 25th 2018, 12:05pm
yoSkeezo @yoSkeezo
$TCON crossed the Keltner Beautifully.... Only a 100k volume 3m but certainly a bullish formation
May 25th 2018, 8:05am
SolarMelt @SolarMelt
$TCON Classic Buy Signal (Broke Above the 50-DMA) with upticks in Accumulation and Money Flow. MACD Crossed Over to… https://t.co/uog5Or1R4I
May 25th 2018, 1:05am
StockTexts @StockTexts
$TCON TRACON Pharmaceuticals, Inc. SEC Filing: Form EFFECT https://t.co/JqaX43bDOe
May 22nd 2018, 6:05am
Stock_News_Now @Stock_News_Now
$TCON: New SEC Filing for TCON: Form 8-K (No. 0001564590-18-014083): https://t.co/pcbMLCGj5I
May 21st 2018, 4:05pm
WeekHerald @WeekHerald
Q2 2018 EPS Estimates for TRACON Pharmaceuticals Lifted by Jefferies Group $TCON https://t.co/XeGDetxer7
May 20th 2018, 6:05am
ZolmaxNews @ZolmaxNews
Q2 2018 EPS Estimates for TRACON Pharmaceuticals Lifted by Jefferies Group $TCON https://t.co/3lbunBTDou
May 20th 2018, 1:05am
ledgerzette @ledgerzette
Q2 2018 EPS Estimates for TRACON Pharmaceuticals $TCON Raised by Jefferies Group https://t.co/55WoZQeygu
May 19th 2018, 6:05am
TheMarketsDaily @TheMarketsDaily
Q2 2018 EPS Estimates for TRACON Pharmaceuticals $TCON Raised by Jefferies Group https://t.co/FTqG6nmwBF
May 19th 2018, 1:05am
dakotafinancial @dakotafinancial
Q2 2018 EPS Estimates for TRACON Pharmaceuticals $TCON Raised by Jefferies Group https://t.co/pWbsMC94Gb
May 19th 2018, 1:05am
MACDcurlingup @MACDcurlingup
$TCON ready for liftoff? MACD cross imminent. https://t.co/IgEr3F8ALq
May 18th 2018, 10:05am
AmericanBanking @AmericanBanking
TRACON Pharmaceuticals Expected to Post Q2 2018 Earnings of -$0.29 Per Share $TCON https://t.co/LYXlWgbu9Z #stocks
May 18th 2018, 7:05am
OlympiaReport @OlympiaReport
TRACON Pharmaceuticals Expected to Post Q2 2018 Earnings of -$0.29 Per Share $TCON https://t.co/kJHre95ju8
May 18th 2018, 7:05am
dispatchtribune @dispatchtribune
TRACON Pharmaceuticals Expected to Post Q2 2018 Earnings of -$0.29 Per Share $TCON https://t.co/3Bx6Hi3VeE
May 18th 2018, 7:05am
WeekHerald @WeekHerald
TRACON Pharmaceuticals $TCON Receives News Impact Score of -0.04 https://t.co/M7XbHVPZhe
May 14th 2018, 4:05pm
ThisLincolnian @ThisLincolnian
TRACON Pharmaceuticals $TCON Given New $8.00 Price Target at Needham & Company LLC https://t.co/v4WtIit8UI
May 14th 2018, 6:05am
TheMarketsDaily @TheMarketsDaily
TRACON Pharmaceuticals $TCON PT Lowered to $8.00 at Needham & Company LLC https://t.co/W75x8l5IKj
May 13th 2018, 11:05am
TranscriptDaily @TranscriptDaily
TRACON Pharmaceuticals $TCON Price Target Cut to $8.00 by Analysts at Needham & Company LLC https://t.co/ifBBv46sRF
May 12th 2018, 2:05am
ZolmaxNews @ZolmaxNews
TRACON Pharmaceuticals $TCON Releases Earnings Results, Misses Estimates By $0.10 EPS https://t.co/bOCM1n1uTj
May 11th 2018, 8:05pm
WatchlistN @WatchlistN
TRACON Pharmaceuticals $TCON Price Target Cut to $8.00 by Analysts at Needham & Company LLC https://t.co/t2ZVgLeWLJ
May 11th 2018, 4:05pm
WeekHerald @WeekHerald
TRACON Pharmaceuticals $TCON Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS https://t.co/LsSh52R55s
May 10th 2018, 9:05pm
WeekHerald @WeekHerald
TRACON Pharmaceuticals $TCON Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS https://t.co/Ze0Mh5QsZ8
May 10th 2018, 9:05pm
TranscriptDaily @TranscriptDaily
TRACON Pharmaceuticals $TCON Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS https://t.co/O45owIUvUa
May 10th 2018, 8:05pm
EnterpriseLeade @EnterpriseLeade
TRACON Pharmaceuticals $TCON Posts Quarterly Earnings Results, Misses Estimates By $0.10 EPS https://t.co/aLjp2djvk6
May 10th 2018, 8:05pm
TheMarketsDaily @TheMarketsDaily
TRACON Pharmaceuticals $TCON Releases Quarterly Earnings Results, Misses Expectations By $0.10 EPS https://t.co/nsVqvOU5zx
May 10th 2018, 8:05pm
dakotafinancial @dakotafinancial
TRACON Pharmaceuticals $TCON Issues Quarterly Earnings Results https://t.co/EWU9tcWiD5
May 10th 2018, 7:05pm
TheMarketsDaily @TheMarketsDaily
TRACON Pharmaceuticals $TCON Releases Quarterly Earnings Results, Misses Expectations By $0.10 EPS https://t.co/n6HSubjacM
May 10th 2018, 7:05pm
ThisLincolnian @ThisLincolnian
TRACON Pharmaceuticals $TCON Issues Quarterly Earnings Results https://t.co/hBy26axtoD
May 10th 2018, 7:05pm
AmericanBanking @AmericanBanking
Needham & Company LLC Lowers TRACON Pharmaceuticals $TCON Price Target to $8.00 https://t.co/57Sr5cFHA1 #stocks
May 10th 2018, 7:05pm
AmericanBanking @AmericanBanking
TRACON Pharmaceuticals $TCON Releases Earnings Results, Misses Estimates By $0.10 EPS https://t.co/lKzng7MYMi #stocks
May 10th 2018, 4:05pm
dispatchtribune @dispatchtribune
TRACON Pharmaceuticals $TCON Releases Earnings Results, Misses Estimates By $0.10 EPS https://t.co/RMuJ62l4KW
May 10th 2018, 4:05pm
OlympiaReport @OlympiaReport
TRACON Pharmaceuticals $TCON Announces Quarterly Earnings Results https://t.co/DHBVkD6imb
May 10th 2018, 4:05pm
AceAnalyst @AceAnalyst
$TCON I’m on the sideline currently. Trend looks like low $2’s are coming
May 10th 2018, 2:05pm
stocknewsdotcom @stocknewsdotcom
$TCON Needham & Co. cuts PT to $8 https://t.co/wIdWDYmpSG
May 10th 2018, 10:05am
trumptrackerbot @trumptrackerbot
$TCON - 10-Q - tax reform bill could adversely affect our business and financial condition. On December 22, 2017, P… https://t.co/2myEQIfSsN
May 10th 2018, 10:05am
trumptrackerbot @trumptrackerbot
$TCON - 10-Q - there have been judicial and Congressional challenges to certain aspects of the ACA. Since January 2… https://t.co/wZDkMSQzLM
May 10th 2018, 10:05am
trumptrackerbot @trumptrackerbot
$TCON - 10-Q - and reform government program reimbursement methodologies for products. At the federal level, Congre… https://t.co/7YoXMFXsgj
May 10th 2018, 10:05am
dailypoliticaln @dailypoliticaln
TRACON Pharmaceuticals $TCON PT Lowered to $8.00 https://t.co/visbnBZHZj
May 10th 2018, 9:05am
WeekHerald @WeekHerald
TRACON Pharmaceuticals $TCON PT Lowered to $8.00 https://t.co/J73sJ6wioi
May 10th 2018, 9:05am
ZolmaxNews @ZolmaxNews
TRACON Pharmaceuticals $TCON PT Lowered to $8.00 https://t.co/zjn8JpW276
May 10th 2018, 9:05am
brockthornhill @brockthornhill
RT @4thQuarterCap: $TCON lots going on for this smallcap in 2H18 trading just above cash. With phase three interim coming up. Plus this is…
May 10th 2018, 6:05am
biostockfan @biostockfan
RT @odibro: $TCON S-3 27M shares shelf filed by selling stockholders https://t.co/rg619pTF3s
May 10th 2018, 6:05am
odibro @odibro
$TCON S-3 27M shares shelf filed by selling stockholders https://t.co/rg619pTF3s
May 10th 2018, 6:05am
4thQuarterCap @4thQuarterCap
$TCON lots going on for this smallcap in 2H18 trading just above cash. With phase three interim coming up. Plus thi… https://t.co/Ek22bwc2pV
May 10th 2018, 12:05am
bdailystocks @bdailystocks
$TCON $ 2.55 +0.050 (2.00%) - News Out on TRACON Pharmaceuticals https://t.co/04hEUVg40P
May 9th 2018, 6:05pm
ConsumerFeed @ConsumerFeed
Somewhat Favorable Press Coverage Somewhat Unlikely to Affect TRACON Pharmaceuticals $TCON Stock Price https://t.co/O8FJxsDh0L
May 9th 2018, 6:05pm
WeekHerald @WeekHerald
TRACON Pharmaceuticals $TCON Receiving Somewhat Favorable Media Coverage, Study Shows https://t.co/j2c1lfYOU5
May 9th 2018, 5:05pm
StockNewsNow @StockNewsNow
$TCON TRACON Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update https://t.co/WK8nIkuFxR
May 9th 2018, 5:05pm
odibro @odibro
$TCON 1Q Financials $62M in cash https://t.co/LooNDQs6hN https://t.co/PufGte7DFT
May 9th 2018, 5:05pm
LifeSciAdvisors @LifeSciAdvisors
TRACON Pharmaceuticals $TCON Reports First Quarter 2018 Financial Results and Provides Corporate Update https://t.co/NtwGcY60WW
May 9th 2018, 4:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.